EPIQ Capital Group, LLC

Average Profitability
23.94%
Insider Buys Quantity
10
Insider Buys Sum
$1.33M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of EPIQ Capital Group, LLC

The largest purchase of all time was on 2020-05-20 and amounted to 6085 shares of Quince Therapeutics, Inc. for $352,605.

Biography of EPIQ Capital Group, LLC

No biography is available at this moment.

2020-06-12PurchaseQuince Therapeutics, Inc.
QNCX
2,440
0.0081%
$44.06$107,506-4.71%
2020-06-11PurchaseQuince Therapeutics, Inc.
QNCX
6,600
0.0221%
$44.32$292,512-4.51%
2020-05-22PurchaseQuince Therapeutics, Inc.
QNCX
2,085
0.0072%
$55.90$116,552-21.99%
2020-05-21PurchaseQuince Therapeutics, Inc.
QNCX
520
0.0017%
$55.80$29,016-23.91%
2020-05-20PurchaseQuince Therapeutics, Inc.
QNCX
6,085
0.0212%
$57.95$352,605-23.86%
2019-08-21PurchaseQuince Therapeutics, Inc.
QNCX
2,055
0.0076%
$24.87$51,105+73.11%
2019-08-20PurchaseQuince Therapeutics, Inc.
QNCX
2,910
0.011%
$25.69$74,758+70.98%
2019-08-19PurchaseQuince Therapeutics, Inc.
QNCX
2,100
0.0079%
$26.50$55,640+65.16%
2019-08-16PurchaseQuince Therapeutics, Inc.
QNCX
700
0.0025%
$26.37$18,460+59.9%
2019-05-10PurchaseQuince Therapeutics, Inc.
QNCX
8,600
0.0614%
$26.98$232,056+49.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.